Company / PP&E per Share
Bristol Myers Squibb PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.63
FY2025
5-year range
$2.77 / $3.63
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#23 of 191
Health Care
What the data says
Bristol Myers Squibb's pp&e per share of $3.63 is higher than 88% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 3 consecutive years, from $2.77 in FY2022 to $3.63 in FY2025.
Based on SEC 10-K filings.
3.63 in FY2025 with a 5-year CAGR of +0.2%. Top quartile in the Health Care sector.
Improved from $2.96 to $3.63 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 191This company $3.63 Sector average $22.34
▼
-83.8% below sector average
Key checks
Key Insights
- Bristol Myers Squibb's pp&e per share has grown for 3 consecutive years.
- In FY2025, pp&e per share increased 9.2% year-over-year.
- Ranks #23 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.63 | +9.2% |
| FY2024 | $3.33 | +12.3% |
| FY2023 | $2.96 | +6.9% |
| FY2022 | $2.77 | -21.6% |
| FY2021 | $3.53 | -1.7% |
| FY2020 | $3.60 | -5.0% |
| FY2019 | $3.78 | +26.5% |
| FY2018 | $2.99 | +0.5% |
| FY2017 | $2.98 | -0.1% |
| FY2016 | $2.98 | +12.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026